Lucky they all got their 424 forms done before the spike. JJ/daniel - GEM - BRPA investors. Not even some follow thru as a fake out to keep interest...JMHFO...
Re Present data to investors and still digging for other barely 'significant data' from some patients to give to FDA. Why not 90 or 180 day data? Maybe some more data not found during initial reviews of CT data. (convoluted/ineptly run by JJ/Dan)... Does anyone see +$30 for this or +$1 for RLF in any near term evaluations? At this point I see huge a reason for an NRLA merge (NRXP/RLF/ACER/etc). But. RLF may have better luck independently?
News 
Market Data 
Discover 
